333 related articles for article (PubMed ID: 22169357)
1. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
[TBL] [Abstract][Full Text] [Related]
2. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
3. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
4. In vivo proton spectroscopy of giant cell tumor of the bone.
Sah PL; Sharma R; Kandpal H; Seith A; Rastogi S; Bandhu S; Jagannathan NR
AJR Am J Roentgenol; 2008 Feb; 190(2):W133-9. PubMed ID: 18212197
[TBL] [Abstract][Full Text] [Related]
5. [Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing tumors of bone and soft tissue].
Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):504-10. PubMed ID: 22338133
[TBL] [Abstract][Full Text] [Related]
6. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA
AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370
[TBL] [Abstract][Full Text] [Related]
7. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
[TBL] [Abstract][Full Text] [Related]
8. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM
Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496
[TBL] [Abstract][Full Text] [Related]
9. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
[TBL] [Abstract][Full Text] [Related]
10. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
11. MR Spectroscopy for Differentiating Benign From Malignant Solid Adnexal Tumors.
Ma FH; Qiang JW; Cai SQ; Zhao SH; Zhang GF; Rao YM
AJR Am J Roentgenol; 2015 Jun; 204(6):W724-30. PubMed ID: 26001263
[TBL] [Abstract][Full Text] [Related]
12. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification.
Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S
Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519
[TBL] [Abstract][Full Text] [Related]
14. [Value of 3T magnetic resonance dynamic contrast-enhanced and diffusion-weighted imaging in differential diagnosis of musculoskeletal tumors].
Qi ZH; Li CF; Ma XX; Yang H; Jiang BD; Zhang K; Yu DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Apr; 34(2):138-45. PubMed ID: 22776599
[TBL] [Abstract][Full Text] [Related]
15. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
[TBL] [Abstract][Full Text] [Related]
16. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
17. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
[TBL] [Abstract][Full Text] [Related]
18. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
[TBL] [Abstract][Full Text] [Related]
20. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
